Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) Shares Up 2.7% – Should You Buy?

Innovator IBD Breakout Opportunities ETF (NYSEARCA:BOUT) was up 2.7% during mid-day trading on Monday . The company traded as high as $36.70 and last traded at $36.70. Approximately 955 shares were traded during mid-day trading, a decline of 50% from the average daily volume of 1,924 shares. The stock had previously closed at $35.73.

Innovator IBD Breakout Opportunities ETF Stock Up 2.7%

The company has a market capitalization of $11.01 million, a price-to-earnings ratio of 28.69 and a beta of 1.08. The business has a 50-day moving average price of $38.12 and a 200-day moving average price of $37.11.

Institutional Trading of Innovator IBD Breakout Opportunities ETF

A number of hedge funds have recently bought and sold shares of BOUT. Osaic Holdings Inc. increased its position in shares of Innovator IBD Breakout Opportunities ETF by 39.7% in the second quarter. Osaic Holdings Inc. now owns 2,102 shares of the company’s stock worth $77,000 after acquiring an additional 597 shares in the last quarter. Comprehensive Wealth Management LLC grew its position in Innovator IBD Breakout Opportunities ETF by 60.5% during the 3rd quarter. Comprehensive Wealth Management LLC now owns 10,544 shares of the company’s stock worth $411,000 after purchasing an additional 3,976 shares in the last quarter. Nova Wealth Management Inc. raised its stake in Innovator IBD Breakout Opportunities ETF by 109.4% during the 1st quarter. Nova Wealth Management Inc. now owns 23,978 shares of the company’s stock valued at $870,000 after purchasing an additional 12,528 shares during the period. Finally, Susquehanna International Group LLP raised its stake in Innovator IBD Breakout Opportunities ETF by 42.6% during the 3rd quarter. Susquehanna International Group LLP now owns 26,176 shares of the company’s stock valued at $1,020,000 after purchasing an additional 7,817 shares during the period.

Innovator IBD Breakout Opportunities ETF Company Profile

The Innovator IBD Breakout Opportunities ETF (BOUT) is an exchange-traded fund that is based on the IBD Breakout Stocks Total Return index. The fund tracks an index of US-listed stocks that are likely to breakout, as determined by technical analysis. Holdings are weighted by a mix of fundamental and technical factors BOUT was launched on Sep 13, 2018 and is managed by Innovator.